How can pharmacists better support patients with chronic diseases? The patient perspective
Journal of the American Pharmacists Association · 2023
DOI: 10.1016/j.japh.2023.08.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2023. Verfasst von Lakesha Butler und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals.
Abstract (Originalsprache)
BACKGROUND: Patients' perceptions of their interaction with pharmacists can affect how they use this resource for chronic disease care. OBJECTIVE: This qualitative study explored pharmacist-patient interactions and patients' perceptions of pharmacists' roles in cardiovascular disease (CVD) and inflammatory bowel disease (IBD). METHODS: Patient volunteers, recruited through Janssen's Patient Engagement Research Council program, completed a 15-minute prework survey before a 90-minute live virtual focus group session to provide feedback on pharmacist-patient interactions, the pharmacist's role in patient care, and recommendations for improvement. RESULTS: In total, 27 patients participated. Among patients with CVD (n=18), 56% were female, 61% aged ≥65 years, and 39%/39% Black/White. Of those with IBD (n=9), 56% were female, 89% aged 25-44 years, and 33%/56% Black/White. In the CVD cohort, patients conversed with their pharmacists at least monthly, on average. Patients were generally happy with their relationship with their pharmacist, viewing pharmacists as a trusted resource for medication information. Polypharmacy was common in the CVD cohort (mean, 10.8 medications). For patients with IBD, pharmacist-patient interactions were less frequent, relationships were generally perceived as transactional, patients took fewer medications (mean, 3.2), and felt uncomfortable discussing their disease in public. All patients (CVD and IBD) were unaware of pharmacists' medical training/knowledge. Recommendations included private spaces for sensitive conversations, phone/text support, in-depth regular check-ins, and proactive communication to highlight that the pharmacist's role is to provide patient-centered holistic care. CONCLUSION: This research demonstrates a lack of understanding of pharmacist training, accessibility and role among patients with chronic disease, and highlights opportunities to amend delivery of care. These insights can be used to inform strategies and approaches tailored to address unique needs of specific patient populations to enhance pharmacist-patient interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Förderung
- Janssen Pharmaceuticals
Zitieren
APA
Butler, L., Zona, S., Patel, A. A., Brittle, C., & Shea, L. (2023). How can pharmacists better support patients with chronic diseases? The patient perspective. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2023.08.023
Vancouver
Butler L, Zona S, Patel AA, Brittle C, Shea L. How can pharmacists better support patients with chronic diseases? The patient perspective. Journal of the American Pharmacists Association. 2023. doi:10.1016/j.japh.2023.08.023
BibTeX
@article{Butler2023,
author = {Butler, Lakesha and Zona, Steven and Patel, Aarti A and Brittle, Christine and Shea, Lisa},
title = {How can pharmacists better support patients with chronic diseases? The patient perspective},
journal = {Journal of the American Pharmacists Association},
year = {2023},
doi = {10.1016/j.japh.2023.08.023}
}
EUVIMED